Predictive Vulnerability Intelligence.

Product

  • Product
  • Pricing
  • Documentation

Company

  • About
  • Partnerships
  • Blog
  • Support

Legal

  • Terms
  • Privacy
  • Data Licensing

© 2026 FAUCET Technologies LLC. All rights reserved.

CVE-2023-33295

21
FAUCET Score

CVE-2023-33295 is an incorrect access control vulnerability affecting Cohesity DataProtect versions prior to 6.8.1_u5 or 7.1, stemming from a lack of TLS certificate validation. With a CVSS score of 6.5 (MEDIUM), this vulnerability allows an authenticated attacker to achieve high confidentiality impact over the network with low attack complexity. There is currently no evidence of active exploitation, public exploit code (Metasploit, Nuclei, ExploitDB), or significant community discussion or media coverage surrounding this CVE.

Impacted Technologies

VendorProductVersion(s)CPE
<= 7.0.1CPE matchmatch criteria
cpe:2.3:a:cohesity:cohesity_dataplatform:*:*:*:*:*:*:*:*

CVSS Data

CVSS version used by this source: 3.1

6.5MEDIUM

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
HIGH
Integrity Impact
NONE
Availability Impact
NONE
Exploitability Score
2.8
Impact Score
3.6
CvssVersion
3.1

Exploit Intelligence

EPSS Score
0.28%
Probability of exploitation in next 30 days
EPSS Percentile
19.9%
Percentile rank of EPSS score among Peer Group
As of 2026-07-27
Model: v2026.06.15
This CVE's current EPSS score of 0.0028 is in the 25th percentile among its peer group of 21,958 CVEs.

Social Chatter

The average CVE in this peer group has 0.0 Twitter, 0.0 Reddit, 0.1 Bluesky, 0.0 Mastodon, and 0.1 GitHub mentions.

Media Mentions

No media coverage found for this CVE.

The average CVE in this peer group has 0.0 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.

Remediation

Remediation records are not available for this CVE.

References

cohesity.com
Product
github.com / cohesity/SecAdvisory/blob/master/CVE-2023-33295.md
Third Party Advisory